Among these inflammatory diseases there are some related to the digestive system and, recently, HERC2 has also been described to promote inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma [51,52,53,54,55] (Figure 1, HERC2 section). This evidence concerns the gene HERC2 and hepatocellular carcinoma.